At the news
? NEUTRALIMPACT 3/10 SC 13G/A filed Nov 16, 2026 at 12:57 ET
Janus Henderson Group Ltd. filed an amended Schedule 13G disclosing a 3.0% passive beneficial ownership stake in Yarrow Bioscience as of September 30, 2026, representing 283,341 shares. This is a new passive disclosure from a large asset manager, adding to a series of recent 13G filings by other institutions following Yarrow's September 2026 equity offering. The stake is below 5% and carries no activist intent.
- Janus Henderson Group Ltd. disclosed a 3.0% beneficial ownership stake in Yarrow Bioscience as of September 30, 2026
- The stake consists of 283,341 shares of common stock
- The filing is an amendment to Schedule 13G, indicating passive investment intent
- Janus Henderson is the ultimate parent of multiple SEC-registered investment advisers and foreign equivalents
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access